R

Rgenta Therapeutics Inc.

21 employees

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Therapeutics
Medical
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$52M

from 13 investors over 13 rounds

R

Rgenta Therapeutics Inc. raised $52M on November 29, 2022

Investors: 经纬创投（北京）投资管理顾问有限公司, Delos Capital, Lilly Asia Ventures, 凯泰资本, 中金公司, Vivo Capital and Lengend Star

R

Rgenta Therapeutics Inc. raised $18M on May 25, 2021

Investors: Lilly Asia Ventures, Vivo Capital and 凯泰资本

R

Rgenta Therapeutics Inc. raised $20M on April 2, 2020

Investors: 经纬创投（北京）投资管理顾问有限公司, Lengend Star and 凯泰资本

FAQ